Zhou Fang

200, 8, 20. 20. 1979 09 —1984 07, 1997 09 —2001 06, 2000 10 —2001 01 (UCLA), 1984 09 —1989 09 1989 10 —1993 02 Doncast 1993 03 —1997 07 1997 08 —2003 07 2003 08 — 2016 2 —2022 8,,,;,;,,, AO AO AO AOTK ISCS SICOT OTC;;;;;;; (1)In vivo study of a bioactive nanoparticle-gelatin composite scaffold for bone defect repair in rabbits (2)Risk factors for implant failure after fractures with fracture of the lateral femoral wall (3)Therapeutic hypothermia effectively reduces elevated extracellular ascorbate concentrations caused by acute spinal cord injury (4)Predictors and reduction techniques for irreducible reverse intertrochanteric fractures (5)Improved bone ingrowth of tricalcium phosphate filled Poly(methyl methacrylate) (PMMA) bone cements in vivo.p (6)Risk factors for implant failure in reverse oblique and transverse intertrochanteric fractures treated with proximal femoral nail antirotation (PFNA) (7)Medial wall fragment involving large posterior cortex in pertrochanteric femur fractures: a notable preoperative risk factor for implant failure (8)Persistent oppression and simple decompression both exacerbate spinal cord ascorbate levels (9)Letter to the editor concerning _Vicenti G, Bizzoca D, Nappi VS, et al. The impact of lag screw in the healing time of distal tibia fractures treated with minimally invasive plate osteosynthesis_ A randomized clinical trial injury. 2020 (10)Medial wall fragment involving large posterior cortex in pertrochanteric femur fractures a notable preoperative risk factor for implant failure 1.,..,2010, 2.,,.,,AO.,2010,,26-55. 3.,..,2015 11 4.,..,2012 7, 5.,,,,.,.,2015 6, 6.,,,,.,.,2015 6, 7.,,,,..,2015 9 8.,,, 36,, 15-25.,,,1998, p1255-1267. 9...,,,.AO ASIF.,2000 7:,16-35 10.,,..,,,.,2003 8:,837-871. 11...,..,2004 12:,229-253. 12.,., 13.,.,..,2006 7: 254-274. 14.,.,.,2008 1:,181-259 15..,.,2009 6;,71-85,124-144 16. 、 、.,, AO.,2010 5, P53-89 17.,.,.,2013 10, 446-585 18.,.,OTC.,2015 4,,145-157 19.,.,,2023